课题基金 / 基金详情

CHARACTERIZE DE NOVO SYNTHESIZED BETULINOL DERIVATIVES: DVLP ANTI HIV DRUGS

CHARACTERIZE DE NOVO SYNTHESIZED BETULINOL DERIVATIVES: DVLP ANTI HIV DRUGS
表征从头合成的桦木醇衍生物:DVLP 抗 HIV 药物
批准号:
7182221
负责人:
Brij Saxena
金额:
$0.1万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2006-06-30

项目摘要

项目成果

Brij Saxena的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: MALDI mass spectrometry has become one of the two important methods driving the application of mass spectrometry in biochemistry. A problem that stands in the way of broad application is the extensive metastable-ion decay exhibited by some molecules. This is a particular problem when a class of molecules has one or more labile groups that undergo reactions with significantly lower fragmentation barriers than those for analytically useful fragmentations. An example is the loss of water, for which there is little information content. The problem is made worse when a mixture is encountered. The composite fragmentation is difficult, if not impossible, to assign. A promising development to overcome this limitation is to initiate the desorption process in the presence of a bath gas. This idea will be pursued for the analysis of samples containing oligosaccharides, glyco and phosphopeptides, sialylated glycolipids, sulfated oligosaccharides, and peptides containing oxidized cysteine residues. Many of these samples are of interest to collaborators of the BU research resource.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHARACTERIZE DE NOVO SYNTHESIZED BETULINOL DERIVATIVES: DVLP ANTI HIV DRUGS
CHARACTERIZATION OF DE NOVO SYNTHESIZED BETULINOL DERIVATIVES: DEVELOP ANTI HIV
BIOCHEMICAL STUDIES ON THE LH-HCG RECEPTOR
BIOCHEMICAL STUDIES ON THE LH-HCG RECEPTOR
海外基金